InnoCore Pharmaceuticals is a leading player in the drug delivery industry, offering a unique and highly tunable polymer platform to control the delivery of drug compounds. Founded in 2003, the company specializes in the formulation, process development, and manufacturing of long-acting and minimally invasive injectable drug delivery products, catering to industries such as Biotechnology, Manufacturing, Pharmaceutical, and Logistics and Delivery. InnoCore's proprietary polymer platform presents various benefits, including solving toxicity challenges, maintaining and increasing the stability and structural integrity of sensitive compounds, sustained release of drug molecules for extended periods, precise control over particle size to prevent absorption by macrophages, ensuring smooth bioavailability, and enabling the use of small needle sizes for patient compliance. The company focuses on developmental collaborations and licensing partnerships, utilizing their exclusive SynBiosys biodegradable polymer technologies to create innovative injectable and implantable drug delivery products. InnoCore's commitment to enhancing the performance of devices and drugs, alongside adding value to product pipelines, positions it as an innovative partner in drug delivery.
There is no investment information
No recent news or press coverage available for InnoCore Pharmaceuticals.